Lipocine (LPCN) Change in Acquisitions & Divestments (2015 - 2025)

Lipocine (LPCN) has 11 years of Change in Acquisitions & Divestments data on file, last reported at $5.9 million in Q3 2025.

• Quarterly Change in Acquisitions & Divestments fell 11.94% year-over-year to $5.9 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $25.1 million (down 32.16% YoY) and the FY2024 annual result came in at $35.4 million, down 1.67% from the prior year.
• Change in Acquisitions & Divestments grew to $5.9 million in Q3 2025, from $4.5 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $25.2 million in Q1 2022 to a low of $450000.0 in Q1 2021.
• A 5-year average of $8.3 million and a median of $6.7 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2021 — Change in Acquisitions & Divestments tumbled 89.66% — and 2022, when it jumped 5506.33%.
• Tracing LPCN's Change in Acquisitions & Divestments over 5 years: stood at $1.4 million in 2021, then jumped by 914.29% to $14.2 million in 2022, then slipped by 14.79% to $12.1 million in 2023, then retreated by 13.22% to $10.5 million in 2024, then sank by 43.81% to $5.9 million in 2025.
• The last three Change in Acquisitions & Divestments figures came in at $5.9 million (Q3 2025), $4.5 million (Q2 2025), and $4.2 million (Q1 2025), per Business Quant data.